Skip to main content
SpringerLink
Log in

Systemic and Localized Inflammatory Diseases of Older Adults

  • Chapter
  • First Online:
Rheumatology for Primary Care Providers

  • 953 Accesses

Abstract

Inflammatory musculoskeletal conditions in older adults can severely impact function and quality of life if left untreated. Therefore, the primary care provider should be attuned to differences between osteoarthritis and conditions such as elderly onset rheumatoid arthritis, polymyalgia rheumatica, crystal arthritis, complex regional pain syndrome, and remitting seronegative symmetrical synovitis with pitting edema. Key diagnostic considerations and initial management steps will be reviewed. Rheumatologic conditions exclusively found in older adults and localized painful musculoskeletal conditions will also be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Rasch EK, Hirsch R, Paulose‐Ram R, Hochberg MC. Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of classification. Arthritis Rheum. 2003;48(4):917–26.

    Article  PubMed  Google Scholar 

  2. Ehrlich GE, Katz WA, Cohen SH. Rheumatoid arthritis in the aged. Geriatrics. 1970;25(2):103–13.

    CAS  PubMed  Google Scholar 

  3. Yazici Y, Paget SA. Elderly-onset rheumatoid arthritis. Rheum Dis Clin N Am. 2000;26(3):517–26.

    Article  CAS  Google Scholar 

  4. Kerr L. Inflammatory arthritis in the elderly. Mt Sinai J Med. 2003;70(1):23–6.

    PubMed  Google Scholar 

  5. Kerr L. Inflammatory arthropathy: a review of rheumatoid arthritis in older patients. Geriatrics. 2004;59(10):32–5.

    PubMed  Google Scholar 

  6. Bongartz T, Glazebrook KN, Kavros SJ, Murthy NS, Merry SP, Franz WB 3rd, Michet CJ, Veetil BM, Davis JM 3rd, Mason TG 2nd, Warrington KJ, Ytterberg SR, Matteson EL, Crowson CS, Leng S, McCollough CH. Dual-energy CT for the diagnosis of gout: an accuracy and diagnostic yield study. Ann Rheum Dis. 2015;74(6):1072–7.

    Article  CAS  PubMed  Google Scholar 

  7. Burke B. Gout in older adults; the atherosclerosis risk in communities study. J Gerontol A Biol Sci Med Sci. 2016;71(4):536–42.

    Article  CAS  PubMed  Google Scholar 

  8. McCarty D. Calcium pyrophosphate dihydrate crystal deposition disease: clinical aspects. Clin Rheum Dis. 1977;3:61–89.

    Article  Google Scholar 

  9. Dieppe PA, Alexander GJ, Jones HE, Doherty M, Scott DG, Manhire A, Watt I. Pyrophosphate arthropathy: a clinical and radiologic study of 105 cases. Ann Rheum Dis. 1982;41:371–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Halverson P, Carrera GF, McCarty DJ. Milwaukee shoulder syndrome: fifteen additional cases and a description of contributing factors. JAMA Intern Med. 1990;150(3):677–82.

    Article  CAS  Google Scholar 

  11. Ea H, Lioté F. Calcium pyrophosphate dihydrate and basic calcium phosphate crystal induced arthropathies: update on pathogenesis, clinical features, and therapy. Curr Rheumatol Rep. 2004;6:221–7.

    Article  PubMed  Google Scholar 

  12. Li H, Altman RD, Yao Q. RS3PE: clinical and research development. Curr Rheumatol Rep. 2015;17(49):1–6.

    Google Scholar 

  13. Griffin MR, Ray WA, Schaffner W. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med. 1998;109(5):359–63.

    Article  Google Scholar 

  14. Kirwan J. The effect of glucocorticoidds on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N Engl J Med. 1995;333(3):142–6.

    Article  CAS  PubMed  Google Scholar 

  15. O’Dell J. Therapeutic strategies for rheumatoid arthritis. N Engl J Med. 2004;350(25):2591–602.

    Article  PubMed  Google Scholar 

  16. O’Dell JR, Haire CE, Erikson N, Drymalski W, Palmer W, Eckhoff PJ, Garwood V, Maloley P, Klassen LW, Wees S, Klein H. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med. 1996;334(20):1287–91.

    Article  PubMed  Google Scholar 

  17. Sugihara T, Harigai M. Targeting low disease activity in elderly-onset rheumatoid arthritis: current and future roles of biological disease-modifying antirheumatic drugs. Drugs Aging. 2016;33(2):97–107.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Widdifield J, Bernatsky S, Paterson JM, Gunraj N, Thorne JC, Pope J, Cividino A, Bombardier C. Serious infections in a population-based cohort of 86,039 seniors with rheumatoid arthritis. Arthritis Care Res. 2013;65(3):353–61.

    Article  Google Scholar 

  19. Pfizer. Xeljanz [package insert]. U.S. Food and Drug Administration website. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/213082s000lbl.pdf. Revised September 2020. Accessed Feb 2021.

  20. Buch MH, Smolen JS, Betteridge N, Breedveld FC, Burmester G, Dörner T, Ferraccioli G, Gottenberg JE, Isaacs J, Kvien TK, Mariette X. Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis. 2011;70(6):909–20.

    Article  CAS  PubMed  Google Scholar 

  21. Alloway JA, Moriarty MJ, Hoogland YT, Nashel DJ. Composition of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis. J Rheumatol. 1993;334:111–13.

    Google Scholar 

  22. Yu TF, Gutman AB. Efficacy of colchicine prophylaxis in gout. Ann Int Med. 1961;55:179–92.

    Article  CAS  PubMed  Google Scholar 

  23. Davison SS. Polymyalgia rheumatica. Arthritis Rheum. 1966;(9):18–23.

    Google Scholar 

  24. Fruth M, Seggewiss A, Kozik J, Martin-Seidel P, Baraliakos X, Braun J. Diagnostic capability of contrast-enhanced pelvic girdle magnetic resonance imaging in polymyalgia rheumatica. Rheumatology (Oxford). 2020;59(10):2864–71.

    Google Scholar 

  25. Pipitone N, Salvarani C. Update on polymyalgia rheumatica. Eur J Int Med. 2013;24:583–9.

    Article  CAS  Google Scholar 

  26. Weyand CM, Goronzy JJ. Clinical practice: giant-cell arteritis and polymyalgia rheumatica. N Engl J Med. 2014;371(1):50–7.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Dejaco C, Ramiro S, Duftner C, Besson FL, Bley TA, Blockmans D, Brouwer E, Cimmino MA, Clark E, Dasgupta B, Diamantopoulos AP. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77(5):636–43.

    Article  PubMed  Google Scholar 

  28. Gonzalez-Gay MA, Ortego-Jurado M, Ercole L, Ortego-Centeno N. Giant cell arteritis: is the clinical spectrum of the disease changing? BMC Geriatr. 2019;19(200):1–7.

    Google Scholar 

  29. Spiera H. Polymyalgia rheumatica. Clin Rheumatol Pract. 1984;2(4):150–60.

    Google Scholar 

  30. Rubenstein E, Maldini C, Gonzalez-Chiappe S, Chevret S, Mahr A. Sensitivity of temporal artery biopsy in the diagnosis of giant cell arteritis: a systematic literature review and meta-analysis. Rheumatology (Oxford). 2020;59(5):1011–20.

    Article  Google Scholar 

  31. Hellmich B, Agueda A, Monti S, Buttgereit F, De Boysson H, Brouwer E, Cassie R, Cid MC, Dasgupta B, Dejaco C, Hatemi G. 2018 update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2020;79(1):19–30.

    Article  PubMed  Google Scholar 

  32. Stamatis P, Turesson C, Willim M, Nilsson JÅ, Englund M, Mohammad AJ. Malignancies in giant cell arteritis: a population-based cohort study. J Rheumatol. 2019;47(3):400–6.

    Article  PubMed  Google Scholar 

  33. Muller S, Hider SL, Belcher J, Helliwell T, Mallen CD. Is cancer associated with polymyalgia rheumatica? A cohort study in the general practice research database. Ann Rheum Dis. 2014;73(10):1769–73.

    Article  PubMed  Google Scholar 

  34. Liozon E, Loustaud-Ratti V, Soria P, Bezanahary H, Fauchais AL, Nadalon S, Rhaiem K, Ly K, Vidal E. Disease associations in 250 patients with temporal (giant cell) arteritis. Presse Med. 2004;33(19):1304–12.

    Article  CAS  PubMed  Google Scholar 

  35. Ungprasert P, Sanguankeo A, Upala S, Knight EL. Risk of malignancy in patients with giant cell arteritis and polymyalgia rheumatica: a systematic review and meta-analysis. Semin Arthritis Rheum. 2014;44(3):366–70.

    Article  PubMed  Google Scholar 

  36. Kerr L. Updates in geriatric care: rheumatologic diseases in the older patient. In: Osmond L, editor. Audio-digest internal medicine, 64. New York; 2017.

    Google Scholar 

  37. He Y, Sawalha AH. Drug-induced lupus erythematosus: an update on drugs and mechanisms. Curr Opin Rheumatol. 2018;30(5):490–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Costa M, Said NR, Zimmermann B. Drug-induced lupus due to anti-tumor necrosis factor alpha agents. Semin Arthritis Rheum. 2008;37(6):381–7.

    Article  CAS  PubMed  Google Scholar 

  39. Katz U, Zandman-Goddard G. Drug-induced lupus: an update. Autoimmun Rev. 2010;10(1):46–50.

    Article  CAS  PubMed  Google Scholar 

  40. Shell D, Perkins R, Cosgarea A. Septic olecranon bursitis: recognition and treatment. J Am Board Fam Pract. 1995;8:217.

    CAS  PubMed  Google Scholar 

  41. Woodward T, Best TM. The painful shoulder: part I. Clinical evaluation. Am Fam Physician. 2000;61(10):3079–88.

    CAS  PubMed  Google Scholar 

  42. Segal NA, Felson DT, Torner JC, Zhu Y, Curtis JR, Niu J, Nevitt MC, Group MO. Greater trochanteric pain syndrome: epidemiology and associated factors. Arch Phys Med Rehabil. 2007;88(8):988–92.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Jensen LK, Eenberg W. Occupation as a risk factor for knee disorders. Scand J Work Environ Health. 1996;22(3):165–75.

    Article  CAS  PubMed  Google Scholar 

  44. Petri M, Hufman SL, Waser G, Cui H, Snabes MC, Verburg KM. Celecoxib effectively treats patients with acute shoulder tendinitis/bursitis. J Rheumatol. 2004;31(8):1614.

    CAS  PubMed  Google Scholar 

  45. Soucacos PN, Johnson EO, Soultanis K, Vekris MD, Theodorou SJ, Beris AE. Diagnosis and management of the osteonecrotic triad of the knee. Orthop Clin North Am. 2004;35(3):371–81.

    Article  PubMed  Google Scholar 

  46. Husain R, Nesbitt J, Tank D, Verastegui MO, Gould ES, Huang M. Spontaneous osteonecrosis of the knee (SONK): the role of MR imaging in predicting clinical outcome. J Orthop. 2020;22:606–11.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Shen Z, Chen Z, Xie Z, et al. Bisphosphonate for spontaneous osteonecrosis of the knee: A protocol for systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore). 2020;99(49):e23123.

    Article  CAS  Google Scholar 

  48. Utsinger PD. Diffuse idiopathic skeletal hyperostosis. Clin Rheum Dis. 1985;11(2):325.

    Article  CAS  PubMed  Google Scholar 

  49. Mata S, Fortin PR, Fitzcharles MA, Starr MR, Joseph L, Watts CS, Gore B, Rosenberg E, Chhem RK, Esdaile JM. A controlled study of diffuse idiopathic skeletal hyperostosis. Clinical features and functional status. Medicine (Baltimore). 1997;76(2):104.

    Google Scholar 

  50. Katzman WB, Huang MH, Kritz‐Silverstein D, Barrett‐Connor E, Kado DM. Diffuse idiopathic skeletal hyperostosis (DISH) and impaired physical function: the Rancho Bernardo study. J Am Geriatr Soc. 2017;65(7):1476.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology and Connective Tissue Research, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA

    Seema Malkana

  2. Division of Rheumatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

    Leslie D. Kerr

Authors
  1. Seema Malkana
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leslie D. Kerr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Seema Malkana .

Editor information

Editors and Affiliations

  1. Mount Sinai Hospital, New York, NY, USA

    Yousaf Ali

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Malkana, S., Kerr, L.D. (2022). Systemic and Localized Inflammatory Diseases of Older Adults. In: Ali, Y. (eds) Rheumatology for Primary Care Providers. Springer, Cham. https://doi.org/10.1007/978-3-030-80699-6_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-80699-6_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-80698-9

  • Online ISBN: 978-3-030-80699-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation